Aaron Ondrey - Apr 4, 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Chief Financial Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey
Stock symbol
RCKT
Transactions as of
Apr 4, 2025
Transactions value $
-$39,647
Form type
4
Date filed
4/8/2025, 04:06 PM
Previous filing
Feb 13, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$39.6K -7.49K -5.46% $5.29 130K Apr 4, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.